KALV vs MSFT: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Microsoft Corporation in 2026
KALV
Kalvista Pharmaceuticals Inc
$27.00
MSFT
Microsoft Corporation
$498.10
Key Metrics Comparison
| Metric | KALV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.44B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | KALV |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 30.7% | 18.4% | KALV |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze KALV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or MSFT a better investment?
Comparing KALV and MSFT: Kalvista Pharmaceuticals Inc has a market cap of $1.44B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and MSFT?
KALV (Kalvista Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or MSFT?
KALV has higher revenue growth at 30.7% vs 18.4% for MSFT.
Which company is more profitable: KALV or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for KALV.
Which is the larger company: KALV or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.44B for KALV.
Should I buy KALV or MSFT in 2026?
Both KALV and MSFT have investment merit. KALV trades at $27.00 while MSFT trades at $498.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and MSFT stock?
Key differences: Market Cap ($1.44B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (30.7% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy KALV or MSFT in 2026?
The choice between KALV and MSFT depends on your investment goals. KALV shows higher revenue growth (30.7%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KALV and MSFT?
KALV (Kalvista Pharmaceuticals Inc) has a market cap of $1.44B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.